Keywords
Last Name

Patricia L. Kavanagh, MD

TitleAssistant Professor
InstitutionBoston University School of Medicine
DepartmentPediatrics
DivisionGeneral Pediatrics
Address88 E. Newton St Vose Hall
Boston MA 02118
Phone(617) 414-3573
ORCID ORCID Icon0000-0002-3312-1576
Other Positions
TitleActive Staff Privileges
InstitutionBoston Medical Center
DepartmentPediatrics

 Self-Described Keywords
  • health services research
  • quality indicators
  • quality of care
  • sickle cell disease
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Taylor C, Kavanagh P, Zuckerman B. Sickle cell trait-neglected opportunities in the era of genomic medicine. JAMA. 2014 Apr 16; 311(15):1495-6.
    View in: PubMed
  2. Parker MG, Barrero-Castillero A, Corwin BK, Kavanagh PL, Belfort MB, Wang CJ. Pasteurized human donor milk use among US level 3 neonatal intensive care units. J Hum Lact. 2013 Aug; 29(3):381-9.
    View in: PubMed
  3. Chawla A, Sprinz PG, Welch J, Heeney M, Usmani N, Pashankar F, Kavanagh P. Weight status of children with sickle cell disease. Pediatrics. 2013 Apr; 131(4):e1168-73.
    View in: PubMed
  4. Kenyon CC, Kavanagh PL, Fiechtner LG, Textor TE, Wang CJ. Setting the agenda for quality improvement in pediatric sickle cell disease. J Natl Med Assoc. 2012 Jul-Aug; 104(7-8):337-41.
    View in: PubMed
  5. Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ. Management of children with sickle cell disease: a comprehensive review of the literature. Pediatrics. 2011 Dec; 128(6):e1552-74.
    View in: PubMed
  6. Wang CJ, Kavanagh PL, Little AA, Holliman JB, Sprinz PG. Quality-of-care indicators for children with sickle cell disease. Pediatrics. 2011 Sep; 128(3):484-93.
    View in: PubMed
  7. Raphael JL, Kavanagh PL, Wang CJ, Mueller BU, Zuckerman B. Translating scientific advances to improved outcomes for children with sickle cell disease: a timely opportunity. Pediatr Blood Cancer. 2011 Jul 1; 56(7):1005-8.
    View in: PubMed
  8. Amendah DD, Mvundura M, Kavanagh PL, Sprinz PG, Grosse SD. Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med. 2010 Apr; 38(4 Suppl):S550-6.
    View in: PubMed
  9. Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer. 2009 Oct; 53(4):642-6.
    View in: PubMed
  10. Kavanagh PL, Adams WG, Wang CJ. Quality indicators and quality assessment in child health. Arch Dis Child. 2009 Jun; 94(6):458-63.
    View in: PubMed
  11. Feinberg E, Kavanagh PL, Young RL, Prudent N. Food insecurity and compensatory feeding practices among urban black families. Pediatrics. 2008 Oct; 122(4):e854-60.
    View in: PubMed
  12. Kavanagh PL, Wang CJ, Therrell BL, Sprinz PG, Bauchner H. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states. Am J Med Genet C Semin Med Genet. 2008 Feb 15; 148C(1):15-22.
    View in: PubMed
  13. Caro JJ, Klittich WS, Raggio G, Kavanagh PL, O'Brien JA, Shomphe LA, Flegel KM, Copley-Merriman C, Sigler C. Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes. Clin Ther. 2000 Jan; 22(1):116-27.
    View in: PubMed
  14. O''Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ. Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 1998 Jul; 21(7):1122-8.
    View in: PubMed
Patricia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department